New genomic prostate cancer test improves risk assessment and surveillance

New prostate cancer test improves risk assessment — Tool tested by UC San Francisco helps identify those best suited for active surveillance – A new genomic test for prostate cancer can help predict whether men are more likely to harbor an aggressive form of the disease, according to a new UC San Francisco study. The test, which improves risk assessment when patients are first diagnosed, can also aid in determining which men are suitable for active surveillance – a way of managing the disease without direct treatment.

New genomic marker for tuberculosis

New genomic marker for tuberculosis may help identify patients who will develop the disease — Study highlights how blood profiling techniques could change patient care – It may soon be possible to identify patients who will develop tuberculosis, as scientists have identified changes in the blood specific to the disease.

Genomic sequencing of difficult breast cancers

Life Technologies, TGen and US Oncology partner on groundbreaking breast cancer sequencing research — First-of-its-kind project will sequence difficult breast cancers to provide insight into treatment strategies – Life Technologies Corporation (NASDAQ: LIFE) announced that it is collaborating with the Translational Genomics Research Institute (TGen) and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have progressed despite multiple other therapies.

New genomic approaches for treating skin diseases

Study finds unexpected bacterial diversity on human skin – Genomic research lays groundwork for new approaches for treating, preventing skin diseases. – The health of our skin – one of the body’s first lines of defense against illness and injury – depends upon the delicate balance between our own cells and the millions of bacteria and other one-celled microbes that live on its surface.

New genomic test to personalize breast cancer treatment

One in eight women in the United States will receive a diagnosis of breast cancer in their lifetime, and it is the second leading cause of cancer-related death in women. Now a new test will help physicians determine the best possible treatment for each patient. – A set of 50 genes can be used to reliably identify the four known types of breast cancer, according to research conducted at Washington University School of Medicine in St. Louis and collaborating institutions.

In US saliva test for COVID-19 approved

In US saliva test for COVID-19 approved

U.S. Food and Drug Administration authorized the first diagnostic test with the option of using home-collected saliva samples for COVID-19 testing. Specifically, the FDA issued

Health Newstrack